Clinical Trials Browser

Neoplasm Metastasis

Hodgkin Disease, Lymphoma, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large B-Cell, Diffuse

Cervical Esophagus Adenocarcinoma

Breast Neoplasms, Edema, Erythema, Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms

Carcinoma, Non-Small-Cell Lung

Esophageal Neoplasms

Neoplasms, Germ Cell and Embryonal, Recurrence

Breast Neoplasms

Squamous Cell Carcinoma of Head and Neck

Glioblastoma, Gliosarcoma

Salivary Gland Neoplasms

Squamous Cell Carcinoma of Head and Neck, Neoplasm Metastasis, Recurrence

Carcinoma, Squamous Cell

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Prostatic Neoplasms

Fallopian Tube Neoplasms, Ovarian Neoplasms

Esophageal Neoplasms

Extensive Stage Lung Small Cell Carcinoma

Small Cell Lung Carcinoma

Breast Neoplasms, Triple Negative Breast Neoplasms

Lung Neoplasms

Prostatic Neoplasms

Carcinoma, Non-Small-Cell Lung

Prostatic Neoplasms

Clinical Stage I Esophageal Adenocarcinoma AJCC v8

Lung Neoplasms

Small Cell Lung Carcinoma

Carcinoma, Non-Small-Cell Lung

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

Triple Negative Breast Neoplasms

Prostatic Neoplasms

Salivary Gland Neoplasms

Carcinoma, Non-Small-Cell Lung

Triple Negative Breast Neoplasms

Breast Neoplasms

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Breast Neoplasms, Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms

Neoplasm Metastasis

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Malignant Solid Neoplasm

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Head and Neck Neoplasms

Fallopian Tube Neoplasms, Ovarian Neoplasms

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms

Squamous Cell Carcinoma of Head and Neck, Oropharyngeal Neoplasms

Esophageal Squamous Carcinoma

Esophageal Neoplasms, Stomach Neoplasms

Clinical Trials

Phase I Trial of Bevacizumab and Temsirolimus in Combination With 1) Carboplatin, 2) Paclitaxel, 3) Sorafenib for the Treatment of Advanced Cancer

Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia

NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal Cancer

Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer

Reduced-dose Carboplatin-doublet-chemotherapy + Cemiplimab vs Cemiplimab Monotherapy in Treatment Naive Older and Frail Patients With Metastatic NSCLC With PD-L1 <50%

STELLAR01

TICE

Concurrent Chemotherapy and Radiation Therapy for Newly Diagnosed Nasal NK Cell Lymphoma

Optimization of Dynamic Neoadjuvant Therapy Strategies for HER2-Positive Breast Cancer Based on HER2-PET/CT Molecular Imaging

Major De-escalation to 30 Gy for Select Human Papillomavirus Associated Oropharyngeal Carcinoma

SC9/ABX

Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas

WOLF

The Quarterback Trial: Reduced Dose Radiotherapy for HPV+ Oropharynx Cancer

A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer

LuCarbo - a Study of 177Lu-PSMA-617 Plus Carboplatin in Metastatic Castrate-resistant Prostate Cancer

IGFBP-2 Vaccine to Prevent Ovarian Cancer Progression in Patients With Serologic Detection of Recurrence

LyRICX

LB-100, Carboplatin, Etoposide, and Atezolizumab for the Treatment of Untreated Extensive-Stage Small Cell Lung Cancer

MOZART

TELESCOPE

Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer

PREDICT

Nivolumab With or Without Ipilimumab or Chemotherapy in Treating Patients With Previously Untreated Stage I-IIIA Non-small Cell Lung Cancer

CHAMP

Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Safety and Efficacy Evaluation of Serplulimab Plus Chemo in SCLC Transformed From EGFR-mutated NSCLC After Treatment

IMMUNOLIFE2

Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin

NeoSACT

Phase I/II Study of PEGylated Arginine Deiminase (ADI-PEG20) With Carboplatin and Cabazitaxel in Men With Aggressive Variant Prostate Cancers (AVPC)

Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing

Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLC

Phase II Trial of Ivonescimab in Combination With Carboplatin + Docetaxel in Patients With Early-Stage Triple Negative Breast Cancer

DespaTIL

Study of Xevinapant With Radiation and Chemotherapy for Patients With Head and Neck Cancer

Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Locally Advanced or Inflammatory Triple Negative Breast Cancer

A Study of Pioglitazone and Carboplatin in Patients With Advanced Solid Tumors

A Study of Cemiplimab With Chemotherapy and Immunotherapy in People With Head and Neck Cancer

Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol

Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients

Study on the Efficacy and Safety of JSKN016 as Neoadjuvant Therapy in Resectable Stage II-III Non-small Cell Lung Cancer Patients

XACT-LUNG

TheraT® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers

Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

First Line Weekly Chemo/Immunotherapy for Metastatic Head/Neck Squamous Cell Carcinoma Patients

Adaptive De-intensified Radiotherapy Using Circulating Tumor DNA in HPV- Associated Oropharyngeal Cancer

Neoadjuvant Therapy With Iparomlimab and Tuvonralimab, Lenvatinib and Chemotherapy in Resectable ESCC

Nivolumab +/- Relatlimab Prior to Chemoradiation With II/III Gastro/Esophageal Cancer